Asset Details
Do you wish to reserve the book?
Prostate-derived Ets factor, an oncogenic driver in breast cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Prostate-derived Ets factor, an oncogenic driver in breast cancer
Do you wish to request the book?
Prostate-derived Ets factor, an oncogenic driver in breast cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Prostate-derived Ets factor, an oncogenic driver in breast cancer
2017
Overview
Prostate-derived Ets factor (PDEF), a member of the Ets family of transcription factors, differs from other family members in its restricted expression in normal tissues and its unique DNA-binding motif. These interesting attributes coupled with its aberrant expression in cancer have rendered PDEF a focus of increasing interest by tumor biologists. This review provides a current understanding of the characteristics of PDEF expression and its role in breast cancer. The bulk of the evidence is consistent with PDEF overexpression in most breast tumors and an oncogenic role for this transcription factor in breast cancer. In addition, high PDEF expression in estrogen receptor–positive breast tumors showed significant correlation with poor overall survival in several independent cohorts of breast cancer patients. Together, these findings demonstrate PDEF to be an oncogenic driver of breast cancer and a biomarker of poor prognosis in this cancer. Based on this understanding and the limited expression of PDEF in normal human tissues, the development of PDEF–based therapeutics for prevention and treatment of breast cancer is also discussed.
Publisher
SAGE Publications,Sage Publications Ltd,SAGE Publishing
Subject
/ Antigens
/ Biomarkers, Tumor - biosynthesis
/ Biomarkers, Tumor - genetics
/ Breast Neoplasms - epidemiology
/ Breast Neoplasms - pathology
/ DNA
/ DNA-Binding Proteins - biosynthesis
/ Estrogen Receptor alpha - genetics
/ Female
/ Gene Expression Regulation, Neoplastic
/ Genomes
/ Humans
/ Kinases
/ Male
/ Proteins
/ Proto-Oncogene Proteins c-ets - biosynthesis
/ Proto-Oncogene Proteins c-ets - genetics
/ Tumors
We currently cannot retrieve any items related to this title. Kindly check back at a later time.